INE09XN01023
INE09XN01023
AKUMS DRUGS AND PHARMA L
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 115.11B EUR | 95.44B EUR | 71.36B EUR | 69.44B EUR |
Enterprise Value | 100.4B EUR | 95.44B EUR | 69.42B EUR | 69.44B EUR |
Valuation Multiples | ||||
Trailing P/E | 39.47x | 32.72x | 27.96x | 40.71x |
Forward P/E | 22.03x | -- | -- | -- |
Price to Sales | 2.56x | 2.12x | 1.64x | 2.17x |
Price to Book | 3.47x | -- | 2.15x | -- |
EV/Revenue | 2.23x | 2.12x | 1.59x | 2.17x |
EV/EBITDA | 18.17x | 13.7x | 10.72x | 15.09x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |